Dublin, June 24, 2021 (GLOBE NEWSWIRE) – The “Global Agrigenomics Market by Application (Crop & Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer), Goals and Region (North America, Europe, APAC, South America, RoW) ) – Forecast until 2026 “ the report was added to ResearchAndMarkets.com offer.
The global agrogenomics market is estimated at USD 3.3 billion in 2021 and is expected to reach USD 5.3 billion by 2026, with a CAGR of 9.7% from 2021 to 2026.
The agrogenomics market is increasingly driven by technological advances in applied genomics systems and services, a demonstrable increase in the efficiency and productivity of current agricultural practices, greater availability of reference genomes and the use of genotyping for genome-wide association studies, genomic prediction and cultivation of genetically modified elite cultivars with desirable characteristics, such as high yield, stress tolerance and resistance to parasites, as well as high yields of milk and meat, better health and increased productivity in the case of livestock.
The large-scale genetic characterization of some of the commercially relevant crops has provided a framework that is applicable to other crops as well. With the growing twin challenges of population growth and climate change, new strategies, including genetic advancements, must be available to producers to address concerns for yield optimization and food security.
Livestock Market Expected To Grow At Highest CAGR Between 2021-2026
The livestock segment is expected to accelerate growth during the forecast period due to the rapid adoption and commercialization of new genotyping platforms and related techniques such as marker-based selection (MAS) and marker-based selection (MAB) to identify complex hereditary traits.
Global demand for food products of animal origin is expected to increase by 70% by 2050. The implementation of advanced genetic technologies in animal production will ensure minimal environmental impact with optimized animal health and fertility.
A shift from traditional animal selection to genomic selection is estimated with the introduction of genome analysis tools. The presence of next-generation sequencers allowed researchers to quickly and efficiently determine single nucleotide polymorphisms associated with commercially important phenotypic traits and to estimate the breeding value (EBV) at an earlier stage of young animals.
Target-assisted selection by goal is expected to grow at the highest CAGR between 2021 and 2026
Marker-assisted selection is expected to grow at the highest rate during the forecast period, as it is cheaper and faster than any conventional phenotypic assay, depending on the trait. Marker-assisted selection or marker-assisted selection (SAM) is an indirect selection process in which a trait of interest is selected on the basis of a marker (morphological, biochemical or DNA / RNA variation) linked to a trait. interest (eg disease resistance, abiotic stress tolerance and quality), rather than the trait itself.
This process has been widely studied and proposed for plant and animal breeding. It uses conventional breeding approaches and does not involve transgenic approaches. Marker assisted selection uses DNA markers associated with desirable traits to select a plant or animal to be included in a breeding program early in its development. This approach greatly reduces the time required to identify varieties or breeds that express the desired trait in a breeding program.
The marker can be the sequence of the gene that determines the trait, but in most cases it is a DNA sequence that is located very close to the gene of interest and is therefore always inherited with the trait. Desirable characteristics include disease resistance, salt tolerance, and high yield. Therefore, DNA markers have enormous potential to improve the efficiency and accuracy of conventional plant breeding through marker-assisted selection.
Illumina HiSeq Family By Sequencer Type Expected To Grow At Highest CAGR Between 2021-2026
The Illumina HiSeq family held the largest share in 2020 and is also expected to grow at the highest rate as it is an efficient ultra-high throughput sequencing system that supports the widest range of applications and study sizes. Based on sequencer type, the Illumina HiSeq family has dominated the agrogenomics market, posting a significant share of in 2020, registering a value of $ 1,393.2 million. It is also the most widely used Next Generation Sequencing (NGS) technology due to its high throughput and outstanding operational performance. It also exhibits greater sensitivity to detect genetic variants at low frequencies.
PacBio and solid sequencers are also expected to show decent growth rates over the forecast period. Ligation sequencing (SOLiD) uses DNA ligase, an enzyme widely used in biotechnology for its ability to ligate double stranded DNA strands.
Agrogenomics market in Asia-Pacific region is expected to grow at the highest CAGR during the forecast period
The Asia-Pacific region is expected to experience the fastest growing growth in the global agrogenomics market with a CAGR of 10.6%. Growth in the region is expected due to progress in research and development activities in India, China and Japan. The availability of high quality reference genomic sequences for the majority of crops has strengthened the basis for functional genomics in the region.
Asia-Pacific is the most populous continent with growing concerns for food and nutrition security. The region also produces important food crops such as rice, wheat, barley, chickpeas and pigeon peas. Full-fledged agrogenomics solutions in key markets in the region can emerge as a powerful tool to achieve zero hunger as a sustainable development goal.
Main topics covered:
2 Research methodology
3 Executive summary
4 premium information
4.1 Brief Overview of the Agrigenomics Market
4.2 Agrigenomics, by type of sequencer, 2021 vs. 2026 (million USD)
4.3 Agrogenomics Market, by Application and Region
4.4 Agrogenomics Market, by Objective
4.5 North America Agrigenomics Market, by Application and Country, 2020
4.6 Impact of COVID-19 on the agrogenomics market
5 Market overview
5.2 Market dynamics
220.127.116.11 Advanced genome analysis tools and techniques are at the forefront of the growth dynamics of agrogenomics
18.104.22.168 Robust growth of grants and funding initiatives propelling the growth of agrogenomics
22.214.171.124 Under-optimized multidisciplinary research approaches and lack of support for infrastructure
126.96.36.199 Public perceptions and regulatory obstacles to genome editing in agriculture
188.8.131.52 Agrigenomics for food and nutrition security and food safety and authenticity
184.108.40.206 Growing opportunities for DNA sequencing in crops and livestock
220.127.116.11 Technological constraints of applied genetics in agriculture
5.3 Impact of COVID-19 on Market Dynamics
5.3.1 COVID-19 has negatively impacted the supply chain and revenue streams of the agrigenomics market
6 industry trends
6.2 Value chain analysis
6.3 Technological analysis
6.3.1 Polymerase chain reaction (PCR)
6.3.2 Quantitative PCR
6.3.5 Microarray technology
6.4 Supply chain analysis
6.5 Ecosystem and market map
18.104.22.168 Regulatory bodies
6.6 Porter’s five forces analysis
6.6.1 Threat of new entrants
6.6.2 Threat of substitutes
6.6.3 Bargaining Power of Suppliers
6.6.4 Bargaining power of buyers
6.6.5 Degree of competition
6.7 YC-YCC offset
6.8 Patent analysis
6.9 Case studies
6.9.1 Case study 1
6.9.2 Case study 2
7 Regulatory framework
8 Agrogenomics Market, By Application
9 Agrogenomics market, by objective
10 Agrogenomics Market, by Sequencer Type
11 Agrogenomics Market, by Region
12 Competitive landscape
13 company profiles
13.1 Key players
13.1.1 Scientific Eurofins
13.1.2 Agilent Technologies, Inc.
13.1.3 Thermo Fisher Scientific, Inc.
13.1.4 LGC Limited
13.1.5 Illumina, Inc.
13.1.7 Neogen Corporation
13.1.8 GalSeq Srl
13.1.9 Biogenetic Services, Inc.
13.1.10 Daicel Arbor Biosciences
13.2 Start-Up / SME
13.2.1 Tecan Genomics, Inc
13.2.2 Genotypic Technology Pvt Ltd
13.2.3 BGI genomics
13.2.5 Tiangen Biotech (Beijing) Co., Ltd.
13.2.6 Nucleome Informatics Pvt Ltd
13.2.7 IGA Technology Services
13.2.8 ArrayGen Technologies Pvt. Ltd.
13.2.9 LC Sciences, LLC
13.2.10 Genomics CD
14 adjacent and related markets
For more information on this report, visit https://www.researchandmarkets.com/r/iy602j